Open AccessEarly multicenter experience of a new balloon expandable MyVal transcatheter heart valve in dysfunctional stenosed right ventricular outflow tract conduits
Author(s) -
Muthukumaran C. Sivaprakasam,
J Raja Vijendra Reddy,
Sengottuvelu Gunasekaran,
Kothandam Sivakumar,
Sreeja Pavithran,
Gopalavilasam Rajagopalan Rohitraj,
M. Jayranganath,
Edwin Francis
Publication year - 2021
Publication title -
annals of pediatric cardiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.292
H-Index - 19
eISSN - 0974-2069
pISSN - 0974-5149
DOI - 10.4103/apc.apc_242_20
Subject(s) - medicine , ventricular outflow tract , tetralogy of fallot , pulmonary valve , stenosis , balloon , cardiology , heart valve , pulmonary artery , asymptomatic , surgery , endocarditis , ventricle , heart disease
Transcatheter pulmonary valve implantation (TPVI) is a surgical alternative for correcting dysfunctional right ventricular outflow tract conduits in previously operated patients. MyVal transcatheter heart valve (THV) (Meril Life Sciences, India), a new transcatheter valve designed for aortic position has not been used for TPVI.